A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB

Clinical trial NCT03530852 · RECRUITING

Trial details

NCT number: NCT03530852
Sponsor: Boston Children's Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Short Bowel Syndrome Malabsorption

Start date: 2018-11-21
Primary completion: 2027-06-30
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.